
Lynx Biosciences
Operator of a biotechnology company intended to offer personalized cancer treatments to patients. The company combines physiologically relevant suspension cell co-culture assays, automated microfluidi...
Valuation
$0
Share Price
N/A
Total Raised
$4.2M
Last Round
N/A